0.6433
price up icon2.99%   0.0048
 
loading

Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
6.06%
16.88
15.92 16.12 17.86 21.25
Operating Income/Loss
6.06%
-16.88
-15.92 -16.12 -17.86 -21.25
Income/Loss From Continuing Operations Before Tax
7.83%
-16.64
-15.44 -15.55 -17.47 -20.13
Income/Loss From Continuing Operations After Tax
7.83%
-16.64
-15.44 -15.43 -18.18 -20.13
Net Income/Loss
7.83%
-16.64
-15.44 -15.43 -18.18 -20.13
Preferred Stock Dividends And Other Adjustments
-
- - - 0.234
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.43%
41.44
41.27 1.2428 41.21 39.12
Diluted Average Shares
0.43%
41.44
41.27 1.2428 41.21 39.12
Basic Earnings Per Share
8.11%
-0.40
-0.37 -0.37 -0.44 -0.52
Diluted Earnings Per Share
8.11%
-0.40
-0.37 -0.37 -0.44 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - 0.234
$83.69
price down icon 0.11%
$22.08
price up icon 2.69%
$32.13
price up icon 1.13%
$102.31
price up icon 0.35%
$164.72
price up icon 1.08%
biotechnology ONC
$328.88
price up icon 2.25%
Capitalizzazione:     |  Volume (24 ore):